(Total Views: 131)
Posted On: 06/26/2019 8:45:40 AM
Post# of 15415

$ZIOP News Article - Ziopharm Oncology Completes Enrollment of Controlled IL-12 plus Opdivo (nivolumab) Phase 1 Combination Trial in Brain Cancer https://marketwirenews.com/news-releases/ziop...17336.html


My Twitter: WhyteStocks